Citadel Advisors LLC Makes New Investment in Carmell Co. (NASDAQ:CTCX)

Citadel Advisors LLC bought a new stake in shares of Carmell Co. (NASDAQ:CTCX) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 187,565 shares of the company’s stock, valued at approximately $54,000. Citadel Advisors LLC owned 0.90% of Carmell as of its most recent filing with the Securities and Exchange Commission (SEC).

Separately, Antara Capital LP bought a new stake in Carmell in the fourth quarter valued at $28,000. Institutional investors own 24.22% of the company’s stock.

Carmell Stock Performance

Shares of NASDAQ CTCX opened at $2.68 on Thursday. The firm has a fifty day simple moving average of $1.29 and a two-hundred day simple moving average of $0.64. Carmell Co. has a 12 month low of $0.17 and a 12 month high of $2.33.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.